Masimo (MASI) Cash from Financing Activities (2009 - 2026)
Masimo's quarterly Cash from Financing Activities came in at -$70.2 million in Q2 2026, down 49.36% year-on-year from -$138.6 million in Q2 2025, and up 67.29% quarter-over-quarter from -$214.6 million in Q1 2026.
Masimo has reported Cash from Financing Activities for 18 years, with the latest figure at -$70.2 million in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities fell 49.36% year-over-year to -$70.2 million; the trailing twelve-month figure through Apr 2026 stood at -$543.9 million (down 271.26% YoY), and the FY2026 full-year result was -$520.7 million, down 314.57% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at -$70.2 million, up from -$214.6 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $518.0 million in Q3 2022, with the low at -$218.4 million in Q3 2025.
- Average Cash from Financing Activities over 5 years is -$23.8 million, with a median of -$30.6 million recorded in 2023.
- Year-over-year, Cash from Financing Activities surged 101.99% in 2024 and plunged 21560.0% in 2026.
- Tracing MASI's Cash from Financing Activities over 5 years: stood at -$4.7 million in 2022, then slumped by 968.09% to -$50.2 million in 2023, then surged by 101.99% to $1.0 million in 2024, then slumped by 21940.0% to -$218.4 million in 2025, then surged by 67.86% to -$70.2 million in 2026.
- The last three Cash from Financing Activities figures came in at -$70.2 million (Q2 2026), -$214.6 million (Q1 2026), and -$218.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | -70.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -70.20 Mn |
| Apr 4, 2026 | -70.20 Mn |
| Jan 3, 2026 | -214.60 Mn |
| Jan 3, 2026 | -214.60 Mn |
| Sep 27, 2025 | -218.40 Mn |
| Sep 27, 2025 | -218.40 Mn |
| Jun 28, 2025 | -40.70 Mn |
| Jun 28, 2025 | -40.70 Mn |
| Mar 29, 2025 | -47.00 Mn |
| Mar 29, 2025 | -47.00 Mn |
| Dec 28, 2024 | 1.00 Mn |
| Dec 28, 2024 | 1.00 Mn |
| Sep 28, 2024 | -9.90 Mn |
| Sep 28, 2024 | -9.90 Mn |
| Jun 29, 2024 | -90.60 Mn |
| Jun 29, 2024 | -90.60 Mn |
| Mar 30, 2024 | -26.10 Mn |
| Mar 30, 2024 | -26.10 Mn |
| Dec 30, 2023 | -50.20 Mn |
| Dec 30, 2023 | -50.20 Mn |
| Sep 30, 2023 | 19.30 Mn |
| Sep 30, 2023 | 19.30 Mn |
| Jul 1, 2023 | -4.90 Mn |
| Jul 1, 2023 | -4.90 Mn |
| Apr 1, 2023 | -35.20 Mn |
| Apr 1, 2023 | -35.20 Mn |
| Dec 31, 2022 | -4.70 Mn |
| Dec 31, 2022 | -4.70 Mn |
| Oct 1, 2022 | 29.30 Mn |
| Oct 1, 2022 | 29.30 Mn |
| Jul 2, 2022 | 518.00 Mn |
| Jul 2, 2022 | 518.00 Mn |
| Apr 2, 2022 | -22.20 Mn |
| Apr 2, 2022 | -22.20 Mn |
| Jan 1, 2022 | -161.35 Mn |
| Jan 1, 2022 | -161.35 Mn |
| Apr 3, 2021 | -139.85 Mn |
| Apr 3, 2021 | -139.85 Mn |
| Sep 26, 2020 | 6.34 Mn |
| Sep 26, 2020 | 6.34 Mn |
| Jun 27, 2020 | 21.37 Mn |
| Jun 27, 2020 | 21.37 Mn |
| Mar 28, 2020 | 11.25 Mn |
| Mar 28, 2020 | 11.25 Mn |
| Dec 28, 2019 | -4.00 Mn |
| Dec 28, 2019 | -4.00 Mn |
| Sep 28, 2019 | 9.77 Mn |
| Sep 28, 2019 | 9.77 Mn |
| Jun 29, 2019 | -21.27 Mn |
| Jun 29, 2019 | -21.27 Mn |
| Mar 30, 2019 | 6.17 Mn |
| Mar 30, 2019 | 6.17 Mn |
| Dec 29, 2018 | 2.13 Mn |
| Dec 29, 2018 | 2.13 Mn |
| Sep 29, 2018 | 22.52 Mn |
| Sep 29, 2018 | 22.52 Mn |
| Jun 30, 2018 | 11.36 Mn |
| Jun 30, 2018 | 11.36 Mn |
| Mar 31, 2018 | -10.23 Mn |
| Mar 31, 2018 | -10.23 Mn |
| Dec 30, 2017 | -17.17 Mn |
| Dec 30, 2017 | -17.17 Mn |
| Sep 30, 2017 | -35.12 Mn |
| Sep 30, 2017 | -35.12 Mn |
| Jul 1, 2017 | 20.93 Mn |
| Jul 1, 2017 | 20.93 Mn |
| Apr 1, 2017 | 27.22 Mn |
| Apr 1, 2017 | 27.22 Mn |
| Dec 31, 2016 | -141.28 Mn |
| Dec 31, 2016 | -141.28 Mn |
| Oct 1, 2016 | -15.44 Mn |
| Oct 1, 2016 | -15.44 Mn |
| Jul 2, 2016 | -54.70 Mn |
| Jul 2, 2016 | -54.70 Mn |
| Apr 2, 2016 | -5.21 Mn |
| Apr 2, 2016 | -5.21 Mn |
| Jan 2, 2016 | -90.72 Mn |
| Jan 2, 2016 | -90.72 Mn |
| Apr 4, 2015 | 2.39 Mn |
| Apr 4, 2015 | 2.39 Mn |
| Sep 27, 2014 | 742,000.00 |
| Sep 27, 2014 | 742,000.00 |
| Jun 28, 2014 | 26.08 Mn |
| Jun 28, 2014 | 26.08 Mn |
| Mar 29, 2014 | 1.83 Mn |
| Mar 29, 2014 | 1.83 Mn |
| Dec 28, 2013 | 974,000.00 |
| Dec 28, 2013 | 974,000.00 |
| Sep 28, 2013 | 578,000.00 |
| Sep 28, 2013 | 578,000.00 |
| Jun 29, 2013 | -7.28 Mn |
| Jun 29, 2013 | -7.28 Mn |
| Mar 30, 2013 | -12.22 Mn |
| Mar 30, 2013 | -12.22 Mn |
| Dec 29, 2012 | -56.59 Mn |
| Dec 29, 2012 | -56.59 Mn |
| Sep 29, 2012 | 485,000.00 |
| Sep 29, 2012 | 485,000.00 |
| Jun 30, 2012 | -11.71 Mn |
| Jun 30, 2012 | -11.71 Mn |
| Mar 31, 2012 | -14.27 Mn |
| Mar 31, 2012 | -14.27 Mn |
| Dec 31, 2011 | -35.74 Mn |
| Dec 31, 2011 | -35.74 Mn |
| Oct 1, 2011 | 400,000.00 |
| Oct 1, 2011 | 400,000.00 |
| Jul 2, 2011 | 2.78 Mn |
| Jul 2, 2011 | 2.78 Mn |
| Apr 2, 2011 | 2.41 Mn |
| Apr 2, 2011 | 2.41 Mn |
| Jan 1, 2011 | -152.84 Mn |
| Jan 1, 2011 | -152.84 Mn |
| Apr 3, 2010 | -110.78 Mn |
| Apr 3, 2010 | -110.78 Mn |
| Oct 3, 2009 | 439,000.00 |
| Oct 3, 2009 | 439,000.00 |